# Life Science Invest

> Life Science Invest is a VC fund in Bromma backing Medical and Biotechnology. See 6 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Bromma, Sweden
- Total investments: 6
- Last investment: Jun 2026
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/life-science-invest
- Website: https://www.lifescienceinvest.se

Life Science Invest is an investment firm that specializes in investment in the field of healthcare digital services and Medtech.

## Contacts

5 contacts available for Life Science Invest. Shizune tracks 1 team members at Life Science Invest. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/life-science-invest?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $682k–$4.6M |
| Pre-Seed | $310k–$500k |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 33% |
| Biotechnology | 2 | 33% |
| Biopharma | 1 | 17% |
| Medical Device | 1 | 17% |
| Pharmaceutical | 1 | 17% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 4 | 67% |
| Pre-Seed | 1 | 17% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Kristofer Klerfalk | Co-Founder, CEO and Board Member | 0 | https://shizune.co/investors/profile/christopher-klerfalk |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Haga Bioscience | Haga Bioscience is a biotechnology research company. | $2.2M | Seed | Jun 03, 2026 |  |
| CubaseBio | Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery. | $4.6M | Seed | Feb 17, 2026 |  |
| SampleFacts | Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection. | $1.8M | Seed | May 09, 2025 |  |
| AAX Biotech | AAX Biotech specializes in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. OurTechnologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies. | $681.9K | Seed | Oct 02, 2024 |  |
| MedVasc | MedVasc has developed Solution a patented medical device that reduces pain when treating varicose veins. | $500K | Pre-Seed | Mar 03, 2024 |  |
| MedVasc | MedVasc has developed Solution a patented medical device that reduces pain when treating varicose veins. | $310K | Pre-Seed | Mar 03, 2023 |  |

6 of 6 investments shown.

## Co-investors
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund, 2 deals together
- [Nordic Science Investments](https://shizune.co/investors/profile/nordic-science-investments) — VC Fund, 2 deals together
- [HJKK Didrikson](https://shizune.co/investors/profile/hjkk-didrikson) — VC Fund, 1 deal together
- [Illumina Ventures](https://shizune.co/investors/profile/illumina-ventures) — VC Fund, 1 deal together
- [Karolinska Institutet Holding](https://shizune.co/investors/profile/karolinska-institutet-holding) — VC Fund, 1 deal together
- [Northislet](https://shizune.co/investors/profile/northislet) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Chalmers Ventures AB](https://shizune.co/investors/profile/chalmers-ventures) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

## Featured in investor lists
- [Health Care VC Funds in Sweden](https://shizune.co/investors/health-care-vc-funds-sweden)
- [Biotechnology Investors in Sweden](https://shizune.co/investors/biotechnology-investors-sweden)
- [Biotechnology VC Funds in Sweden](https://shizune.co/investors/biotechnology-vc-funds-sweden)
- [Biotech Investors in Sweden](https://shizune.co/investors/biotech-investors-sweden)
- [Biotech VC Funds in Sweden](https://shizune.co/investors/biotech-vc-funds-sweden)
- [Medical VC Funds in Sweden](https://shizune.co/investors/medical-vc-funds-sweden)

## FAQ

### What does Life Science Invest invest in?

Life Science Invest invests primarily in Medical, Biotechnology and Biopharma startups, most often at Seed and Pre-Seed stage. Most of the 6 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Life Science Invest's check size?

Life Science Invest typically joins rounds of $682k–$4.6M at Seed and $310k–$500k at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Life Science Invest participates in.

### How do I contact Life Science Invest?

Public channels for Life Science Invest include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Life Science Invest?

The team at Life Science Invest includes Kristofer Klerfalk (Co-Founder, CEO and Board Member). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co
